Free Trial

Brokers Issue Forecasts for Maximus' Q1 Earnings (NYSE:MMS)

Maximus logo with Business Services background

Key Points

  • Zacks Research has raised its Q1 2026 earnings per share estimate for Maximus to $1.58, up from a prior estimate of $1.46, and maintains a "Strong-Buy" rating on the stock.
  • Maximus has a current consensus target price of $90.00, although it faced a downgrade from Wall Street Zen from "buy" to "hold" in May.
  • The company recently announced a quarterly dividend of $0.30, translating to an annualized dividend yield of 1.4%, with a payout ratio of 22.10%.
  • MarketBeat previews the top five stocks to own by October 1st.

Maximus, Inc. (NYSE:MMS - Free Report) - Analysts at Zacks Research upped their Q1 2026 EPS estimates for Maximus in a research report issued on Thursday, August 28th. Zacks Research analyst Team now forecasts that the health services provider will earn $1.58 per share for the quarter, up from their previous forecast of $1.46. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for Maximus' current full-year earnings is $6.15 per share. Zacks Research also issued estimates for Maximus' Q2 2026 earnings at $1.52 EPS, FY2026 earnings at $6.43 EPS and Q2 2027 earnings at $1.45 EPS.

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to MarketBeat, Maximus presently has an average rating of "Strong Buy" and an average price target of $90.00.

Get Our Latest Stock Analysis on Maximus

Maximus Stock Performance

NYSE MMS traded down $0.69 during trading on Monday, hitting $87.87. 185,605 shares of the company's stock traded hands, compared to its average volume of 567,877. The stock has a market capitalization of $4.95 billion, a price-to-earnings ratio of 16.17 and a beta of 0.61. Maximus has a 12-month low of $63.77 and a 12-month high of $93.94. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The business has a 50 day moving average of $77.50 and a 200-day moving average of $72.08.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's revenue was up 2.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board purchased a new position in Maximus during the 2nd quarter valued at about $35,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after acquiring an additional 526 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after acquiring an additional 294 shares in the last quarter. Finally, Bayforest Capital Ltd purchased a new stake in shares of Maximus in the 2nd quarter valued at about $61,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's payout ratio is presently 22.10%.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Earnings History and Estimates for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.